Table CFinal, intermediate, and adverse outcomes with insufficient data

Population: device categoryOutcome with insufficient data
STEMI: Catheter aspiration devices versus distal balloon embolic protection devicesAll outcomes
STEMI: Catheter aspiration devices versus catheter aspiration devicesAll outcomes
STEMI: Catheter aspiration devices versus controlStroke, HRQoL, perforation
STEMI: Mechanical thrombectomy devices versus controlMortality, myocardial infarction, stroke, target revascularization, MACE, HRQoL, no reflow, coronary dissection, perforation
STEMI: Distal filter embolic protection devices versus controlMortality, myocardial infarction, stroke, HRQoL, distal embolization, no reflow, coronary dissection, perforation, prolonged procedure time
STEMI: Distal balloon embolic protection devices versus controlMortality, myocardial infarction, stroke, target revascularization, MACE, HRQoL, distal embolization, no reflow, coronary dissection, perforation
STEMI: Proximal embolic protection devices versus controlMortality, myocardial infarction, stroke, target revascularization, MACE, HRQoL, ST-segment resolution, ejection fraction, MBG-3, TIMI-3, distal embolization, no reflow, coronary dissection, perforation
STEMI: Combined embolic protection devices versus controlMortality, myocardial infarction, stroke, target revascularization, HRQoL, no reflow, coronary dissection, perforation
Mixed ACS: Catheter aspiration devices versus controlMortality, myocardial infarction, stroke, target revascularization, MACE, HRQoL, ST-segment resolution, ejection fraction, TIMI-3, distal embolization, no reflow, coronary dissection, perforation, prolonged procedure time
Mixed ACS: Mechanical thrombectomy devices versus controlMortality, myocardial infarction, stroke, target revascularization, MACE, HRQoL, ejection fraction, MBG-3, TIMI-3, distal embolization, no reflow, coronary dissection, perforation, prolonged procedure time
Mixed ACS: Distal filter embolic protection devices versus controlAll outcomes
Mixed ACS: Distal balloon embolic protection devices versus controlMortality, myocardial infarction, stroke, target revascularization, MACE, HRQoL, ejection fraction, TIMI-3, distal embolization, coronary dissection, perforation
Mixed ACS: Proximal balloon embolic protection devices versus controlAll outcomes
Mixed ACS: Combined embolic protection devices versus controlMortality, myocardial infarction, stroke, target revascularization, MACE, HRQoL, ejection fraction, TIMI-3, distal embolization, coronary dissection, perforation
UA/NSTEMI: Catheter aspiration devices versus controlAll outcomes
UA/NSTEMI: Mechanical thrombectomy devices versus controlAll outcomes
UA/NSTEMI: Distal filter embolic protection devices versus controlAll outcomes
UA/NSTEMI: Distal balloon embolic protection devices versus controlAll outcomes
UA/NSTEMI: Proximal embolic protection devices versus controlAll outcomes
UA/NSTEMI: Combined embolic protection devices versus controlAll outcomes

Note: ”All outcomes” includes all 15 final, intermediate, and adverse outcomes evaluated: mortality, myocardial infarction, stroke, target revascularization, MACE, HRQoL, ST-segment resolution, ejection fraction, MBG-3, TIMI-3, distal embolization, no reflow, coronary dissection, perforation, and prolonged procedure time.

ACS = acute coronary syndrome; HRQoL = health-related quality of life; MACE = major adverse cardiovascular event; MBG = myocardial blush grade; NSTEMI = non–ST-segment elevation myocardial infarction; STEMI = ST=segment elevation myocardial infarction; TIMI = thrombolysis in myocardial infarction; UA = unstable angina.

From: Executive Summary

Cover of Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention [Internet].
Comparative Effectiveness Reviews, No. 42.
Sobieraj DM, White CM, Kluger J, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.